2026 FDA Approvals: Infectious Disease Vaccines

The US Food and Drug Administration (FDA) issued vaccine approvals and expanded indications this year, spanning RSV, influenza, pneumococcal disease, and COVID-19. GSK's Arexvy gained clearance for younger at-risk adults, Moderna secured approval for its first mRNA flu vaccine, and Merck's Capvaxive expanded into pediatric populations with underlying conditions.